Wu Xiaoben, Wang Xingbang, Wang Jing, Hao Yingying, Liu Fang, Wang Xin, Yang Lei, Lu Zhiming
Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Department of Neurology, Qilu Hospital, Shandong University, Jinan, China.
Front Oncol. 2021 Oct 13;11:733529. doi: 10.3389/fonc.2021.733529. eCollection 2021.
Glioma is a common type of tumor originating in the brain. Glioma develops in the gluey supporting cells (glial cells) that surround and support nerve cells. Exosomes are extracellular vesicles that contain microRNAs, messenger RNA, and proteins. Exosomes are the most prominent mediators of intercellular communication, regulating, instructing, and re-educating their surrounding milieu targeting different organs. As exosomes' diameter is in the nano range, the ability to cross the blood-brain barrier, a crucial obstacle in developing therapeutics against brain diseases, including glioma, makes the exosomes a potential candidate for delivering therapeutic agents for targeting malignant glioma. This review communicates the current knowledge of exosomes' significant roles that make them crucial future therapeutic agents and diagnostic tools for glioma.
胶质瘤是一种常见的起源于大脑的肿瘤类型。胶质瘤发生于围绕并支持神经细胞的胶质支持细胞(神经胶质细胞)中。外泌体是包含微小RNA、信使RNA和蛋白质的细胞外囊泡。外泌体是细胞间通讯最主要的介质,可调节、指导并重塑其周围针对不同器官的微环境。由于外泌体的直径处于纳米范围,其穿越血脑屏障的能力使其成为递送治疗药物以靶向恶性胶质瘤的潜在候选者,而血脑屏障是开发针对包括胶质瘤在内的脑部疾病的治疗方法的关键障碍。本文综述阐述了外泌体的重要作用的当前知识,这些作用使其成为未来治疗胶质瘤的关键治疗药物和诊断工具。